In addition to post-infarction remodeling, the suppression of Capn4 or the constitutive overexpression of calpastatin attenuated cardiomyocyte hypertrophy and cardiac dysfunction induced by chronic angiotensin II treatment [39,99]. The gene discussed is CAST; the disease is infarction.